Imbalanced activation of cells and previously unknown neural connections may be responsible for some motor symptoms in Parkinson’s disease and similar neurodegenerative conditions, according to two recent studies.
More than 350 participants attended the Mesulam Center for Cognitive Neurology and Alzheimer’s Disease’s virtual PPA Conference, which featured keynote speakers and group support sessions focused on Primary Progressive Aphasia.
Prolonging a cellular defense response to inflammation could help regenerate the protective coating of axons that is degraded in diseases such as multiple sclerosis, according to a recent study.
Northwestern’s investment in next-generation sequencing is leading to unprecedented avenues of discovery.
Northwestern Medicine scientists have discovered a conformational “switch” that determines the function of the SNARE protein Ykt6, with implications for synucleinopathies, according to a recent study.
Northwestern and Lurie Children’s Hospital investigators have been approved for a $4 million funding award by the Patient-Centered Outcomes Research Institute (PCORI) to study Lennox-Gastaut Syndrome.
An experimental spherical nucleic acid drug developed by Northwestern scientists was able to penetrate the blood-brain barrier and trigger the death of glioblastoma cells.
Northwestern Medicine scientists discovered mutations in a scaffolding protein contributes to dystonia, an incurable movement disorder.
Blocking the arginine methylation pathway, which helps brain tumor cells proliferate by promoting cell division, could improve cancer therapies, according to a recent study.
For the first time, Northwestern Medicine scientists have characterized how a genetic mutation associated with pediatric epilepsy affects neuron activity.